Advertisement

Tired of Being Ignored: Fatigue as a Presenting Symptom in Primary Hyperparathyroidism

Published:February 24, 2021DOI:https://doi.org/10.1016/j.jss.2021.01.029

      Abstract

      Background

      Fatigue is a common presenting symptom in primary hyperparathyroidism (PHPT). Although fatigue alone is not currently an indication for parathyroidectomy, it can have a significant detrimental effect on quality of life. The purpose of this study was to determine if there are underlying differences in demographic or disease characteristics in patients with PHPT who present with fatigue compared with those who do not.

      Methods

      We reviewed a prospective database of 2197 patients undergoing parathyroidectomy for PHPT by three endocrine surgeons from 2001 to 2019. Patients were divided into two groups based on the presence or absence of fatigue as a presenting symptom. Objective measures of disease severity were then compared between groups.

      Results

      A total of 1379 (63%) patients presented with fatigue. Patients presenting with fatigue were more likely to be female and to have a prior fracture, lower preoperative serum calcium (Ca), and normocalcemic PHPT. There were no statistically significant differences between groups in age, body mass index, history of nephrolithiasis, or preoperative serum parathyroid hormone levels. Patients presenting with fatigue were also more likely to have smaller parathyroid glands and multiglandular disease. No statistically significant differences were detected in postoperative serum Ca and parathyroid hormone levels, or cure or recurrence rates.

      Conclusions

      Patients with PHPT who report fatigue as a presenting symptom present with more complex disease as manifested by a higher incidence of multiglandular disease and normocalcemic PHPT. Despite this, surgical cure is equivalent to other patients. Therefore, fatigue should be a discrete indication for parathyroidectomy in PHPT.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Surgical Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Chen H.
        • Sokoll L.J.
        • Udelsman R.
        Outpatient minimally invasive parathyroidectomy: a combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay.
        Surgery. 1999; 126: 1016-1022
        • Chen H.
        • Mack E.
        • Starling J.R.
        A comprehensive evaluation of peri-operative adjuncts during minimally invasive parathyroidectomy: which is most reliable?.
        Ann Surg. 2005; 242: 375
        • Balentine C.J.
        • Xie R.
        • Kirklin J.K.
        • Chen H.
        Failure to diagnose hyperparathyroidism in 10,432 patients with hypercalcemia: opportunities for system-level intervention to increase surgical referrals and cure.
        Ann Surg. 2017; 266: 632-640
        • Bilezikian J.P.
        • Brandi M.L.
        • Eastell R.
        • et al.
        Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop.
        J Clin Endocrinol Metab. 2014; 99: 3561-3569
        • Murray S.E.
        • Pathak P.R.
        • Pontes D.S.
        • et al.
        Timing of symptom improvement after parathyroidectomy for primary hyperparathyroidism.
        Surgery. 2013; 154: 1463-1469
        • Roman S.A.
        • Sosa J.A.
        • Mayes L.
        • et al.
        Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism.
        Surgery. 2005; 138 (discussion 1128-9): 1121-1129
        • Gomez-Ramirez J.
        • Gomez-Valdazo A.
        • Luengo P.
        • Porrero B.
        • Osorio I.
        • Rivas S.
        Comparative prospective study on the presentation of normocalcemic primary hyperparathyroidism. Is it more aggressive than the hypercalcemic form?.
        Am J Surg. 2020; 219: 150-153
        • Boone D.
        • Politz D.
        • Lopez J.
        • Mitchell J.
        • Parrack K.
        • Norman J.
        Concentration of serum calcium is not correlated with symptoms or severity of primary hyperparathyroidism: an examination of 20,081 consecutive adults.
        Surgery. 2017; 161: 98-106
        • Eigelberger M.S.
        • Cheah W.K.
        • Ituarte P.H.
        • Streja L.
        • Duh Q.Y.
        • Clark O.H.
        The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited?.
        Ann Surg. 2004; 239: 528-535
        • Mak N.T.J.J.
        • Li J.
        • Vasilyeva E.
        • et al.
        Intraoperative parathyroid hormone measurement during parathyroidectomy for treatment of primary hyperparathyroidism: when should you end the operation?.
        Am J Surg. 2020; 219: 785-789
        • Corbetta S.
        Normocalcemic hyperparathyroidism.
        Front Horm Res. 2019; 51: 23-39
        • Tuna M.M.
        • Çalışkan M.
        • Ünal M.
        • et al.
        Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism.
        J Bone Miner Metab. 2016; 34: 331-335
        • Fazendin J.M.
        • Lindeman B.
        • Chen H.
        Preoperative parathyroid localization does not improve surgical outcomes for patients with primary hyperparathyroidism.
        Am J Surg. 2020; 220: 533-535
        • Khokar A.M.
        • Kuchta K.M.
        • Moo-Young T.A.
        • Winchester D.J.
        • Prinz R.A.
        Increasing trend of bilateral neck exploration in primary hyperparathyroidism.
        Am J Surg. 2020; 219: 466-470
        • Pandian T.K.
        • Lubitz C.C.
        • Bird S.H.
        • Kuo L.E.
        • Stephen A.E.
        Normocalcemic hyperparathyroidism: a collaborative endocrine surgery quality improvement program analysis.
        Surgery. 2020; 167: 168-172
        • Morris G.S.
        • Grubbs E.G.
        • Hearon C.M.
        • et al.
        Parathyroidectomy improves functional capacity in “asymptomatic” older patients with primary hyperparathyroidism: a randomized control trial.
        Ann Surg. 2010; 251: 832-837
        • Kristoffersson A.
        • Bostrom A.
        • Soderberg T.
        Muscle strength is improved after parathyroidectomy in patients with primary hyperparathyroidism.
        Br J Surg. 1992; 79: 165-168
        • Beysel S.
        • Caliskan M.
        • Kizilgul M.
        • et al.
        Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism.
        BMC Cardiovasc Disord. 2019; 19: 106
        • Sho S.
        • Kuo E.J.
        • Chen A.C.
        • Li N.
        • Yeh M.W.
        • Livhits M.J.
        Biochemical and skeletal outcomes of parathyroidectomy for normocalcemic (incipient) primary hyperparathyroidism.
        Ann Surg Oncol. 2019; 26: 539-546
        • Wilhelm S.M.
        • Wang T.S.
        • Ruan D.T.
        • et al.
        The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism.
        JAMA Surg. 2016; 151: 959-968